ADENOSINE THERAPEUTICS
Adenosine Therapeutics (ATL), located in Charlottesville, VA, is a drug discovery and development company that was co-founded in 1999 by University of Virginia (UVa) Professor Joel Linden and entrepreneur Robert Capon (one of three cofounders of Virologic, NASDAQ: VLGC.) Through an in-license agreement with the University of Virginia Patent Foundation, ATL was granted exclusive, worldwide rights to the University's adenosine-related patent portfolio, including apadenoson, developed as Stedivaze, a cardiac stress agent for use in diagnosis of coronary artery disease. Stedivaze was shepherded by ATL to the end of Phase II development before ATL sold substantially all its assets to Clinical Data, Inc. (CLDA) in 2008. CLDA and its successors carried on development into late Phase III.
ADENOSINE THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
1999-01-01
Address:
Charlottesville, Virginia, United States
Country:
United States
Website Url:
http://www.adenrx.com
Total Employee:
11+
Status:
Active
Contact:
(434)220-9400
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Google Apps For Business GoDaddy DNS GoDaddy
Similar Organizations
Summit Therapeutics
Summit Therapeutics is a clinical-stage drug discovery and development company.
Current Employees Featured
Investors List
Emerging Technology Partners
Emerging Technology Partners investment in Venture Round - Adenosine Therapeutics
